Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

PAPSS2-related brachyolmia: Clinical and radiological phenotype in 18 new cases.

Bownass L, Abbs S, Armstrong R, Baujat G, Behzadi G, Berentsen RD, Burren C, Calder A, Cormier-Daire V, Newbury-Ecob R, Foulds N, Juliusson PB, Kant SG, Lefroy H, Mehta SG, Merckoll E, Michot C, Monsell F, Offiah AC, Richards A, Rosendahl K, Rustad CF, Shears D, Tveten K, Wellesley D, Wordsworth P; Deciphering Developmental Disorders Study, Smithson S.

Am J Med Genet A. 2019 Jul 16. doi: 10.1002/ajmg.a.61282. [Epub ahead of print]

PMID:
31313512
2.

Melorheostosis and Osteopoikilosis: A Review of Clinical Features and Pathogenesis.

Wordsworth P, Chan M.

Calcif Tissue Int. 2019 May;104(5):530-543. doi: 10.1007/s00223-019-00543-y. Epub 2019 Apr 15. Review.

PMID:
30989250
3.

RUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis-Novel Targets for Therapy?

Vecellio M, Cohen CJ, Roberts AR, Wordsworth PB, Kenna TJ.

Front Immunol. 2019 Jan 10;9:3132. doi: 10.3389/fimmu.2018.03132. eCollection 2018. Review.

4.

Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases.

Ntusi NAB, Francis JM, Sever E, Liu A, Piechnik SK, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD.

Int J Cardiol. 2018 Nov 1;270:253-259. doi: 10.1016/j.ijcard.2018.06.099. Epub 2018 Jun 25.

PMID:
30017519
5.

The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis.

Watts L, Karaderi T, Roberts A, Appleton L, Wordsworth T, Cohen C, Wordsworth P, Vecellio M.

Genes Immun. 2019 Feb;20(2):167-171. doi: 10.1038/s41435-018-0017-0. Epub 2018 Mar 10.

PMID:
29535371
6.

Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients.

Ntusi NAB, Francis JM, Gumedze F, Karvounis H, Matthews PM, Wordsworth PB, Neubauer S, Karamitsos TD.

Hellenic J Cardiol. 2019 Jan - Feb;60(1):28-35. doi: 10.1016/j.hjc.2018.01.008. Epub 2018 Jan 31.

7.

ERAP1 association with ankylosing spondylitis is attributable to common genotypes rather than rare haplotype combinations.

Roberts AR, Appleton LH, Cortes A, Vecellio M, Lau J, Watts L, Brown MA, Wordsworth P.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):558-561. doi: 10.1073/pnas.1618856114. Epub 2017 Jan 3.

8.

Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia.

Forestier-Zhang L, Watts L, Turner A, Teare H, Kaye J, Barrett J, Cooper C, Eastell R, Wordsworth P, Javaid MK, Pinedo-Villanueva R.

Orphanet J Rare Dis. 2016 Nov 28;11(1):160.

9.

The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases.

Javaid MK, Forestier-Zhang L, Watts L, Turner A, Ponte C, Teare H, Gray D, Gray N, Popert R, Hogg J, Barrett J, Pinedo-Villanueva R, Cooper C, Eastell R, Bishop N, Luqmani R, Wordsworth P, Kaye J.

Orphanet J Rare Dis. 2016 Nov 8;11(1):150.

10.

Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease.

Robinson PC, Leo PJ, Pointon JJ, Harris J, Cremin K, Bradbury LA, Stebbings S, Harrison AA; Australian Osteoporosis Genetics Consortium; Wellcome Trust Case Control Consortium; Management Committee; Data and Analysis Group; DNA, Genotyping, Data QC and Informatics Group; Publications Committee, Duncan EL, Evans DM, Wordsworth PB, Brown MA.

NPJ Genom Med. 2016 May 4;1:16008. doi: 10.1038/npjgenmed.2016.8. eCollection 2016.

11.

Chiari malformation, syringomyelia and bulbar palsy in X linked hypophosphataemia.

Watts L, Wordsworth P.

BMJ Case Rep. 2015 Nov 11;2015. pii: bcr2015211961. doi: 10.1136/bcr-2015-211961.

12.

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.

Hammitzsch A, Tallant C, Fedorov O, O'Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M, Wells C, Wordsworth P, Müller S, Knapp S, Bowness P.

Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10768-73. doi: 10.1073/pnas.1501956112. Epub 2015 Aug 10.

13.

Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study.

Baraliakos X, Borah B, Braun J, Baeten D, Laurent D, Sieper J, Emery P, McInnes IB, van Laar JM, Wordsworth P, Wollenhaupt J, Kellner H, Colin L, Vandenhende F, Radford K, Hueber W.

Ann Rheum Dis. 2016 Feb;75(2):408-12. doi: 10.1136/annrheumdis-2015-207544. Epub 2015 Aug 6.

PMID:
26248638
14.

Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.

Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD.

JACC Cardiovasc Imaging. 2015 May;8(5):526-536. doi: 10.1016/j.jcmg.2014.12.025. Epub 2015 Apr 15.

15.

Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease.

Antonopoulos AS, Margaritis M, Coutinho P, Digby J, Patel R, Psarros C, Ntusi N, Karamitsos TD, Lee R, De Silva R, Petrou M, Sayeed R, Demosthenous M, Bakogiannis C, Wordsworth PB, Tousoulis D, Neubauer S, Channon KM, Antoniades C.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2151-9. doi: 10.1161/ATVBAHA.114.303828. Epub 2014 Jul 24.

PMID:
25060790
16.

A new acro-osteolysis syndrome caused by duplications including PTHLH.

Gray MJ, van Kogelenberg M, Beddow R, Morgan T, Wordsworth P, Shears DJ, Robertson SP, Hurst JA.

J Hum Genet. 2014 Sep;59(9):484-7. doi: 10.1038/jhg.2014.58. Epub 2014 Jul 10.

PMID:
25007883
17.

Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study.

Muñoz-Ortego J, Vestergaard P, Rubio JB, Wordsworth P, Judge A, Javaid MK, Arden NK, Cooper C, Díez-Pérez A, Prieto-Alhambra D.

J Bone Miner Res. 2014 Aug;29(8):1770-6. doi: 10.1002/jbmr.2217.

18.

Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.

Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, Robson MD, Moon J, Wordsworth PB, Neubauer S, Karamitsos TD.

J Cardiovasc Magn Reson. 2014 Mar 4;16:21. doi: 10.1186/1532-429X-16-21.

19.

Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study.

Orozco G, Viatte S, Bowes J, Martin P, Wilson AG, Morgan AW, Steer S, Wordsworth P, Hocking LJ; UK Rheumatoid Arthritis Genetics Consortium; Wellcome Trust Case Control Consortium; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Consortium, Barton A, Worthington J, Eyre S.

Arthritis Rheumatol. 2014 Jan;66(1):24-30. doi: 10.1002/art.38196.

20.

Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking.

Scott IC, Seegobin SD, Steer S, Tan R, Forabosco P, Hinks A, Eyre S, Morgan AW, Wilson AG, Hocking LJ, Wordsworth P, Barton A, Worthington J, Cope AP, Lewis CM.

PLoS Genet. 2013;9(9):e1003808. doi: 10.1371/journal.pgen.1003808. Epub 2013 Sep 19. Erratum in: PLoS Genet. 2013 Oct;9(10). doi:10.1371/annotation/a86ab397-f58c-4144-a241-4957836a728a.

21.

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.

Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Wei J, Brachat A, Bek S, Laurent D, Li Y, Wang YA, Bertolino AP, Gsteiger S, Wright AM, Hueber W.

Lancet. 2013 Nov 23;382(9906):1705-13. doi: 10.1016/S0140-6736(13)61134-4. Epub 2013 Sep 13. Erratum in: Lancet. 2014 May 3;383(9928):1548.

PMID:
24035250
22.

Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data.

McAllister K, Yarwood A, Bowes J, Orozco G, Viatte S, Diogo D, Hocking LJ, Steer S, Wordsworth P, Wilson AG, Morgan AW; UK Rheumatoid Arthritis Genetics Consortium; Rheumatoid Arthritis Consortium International, Kremer JM, Pappas D, Gregersen P, Klareskog L, Plenge R, Barton A, Greenberg J, Worthington J, Eyre S.

Arthritis Rheum. 2013 Dec;65(12):3058-62. doi: 10.1002/art.38183.

23.

ERAP1 and ankylosing spondylitis.

Keidel S, Chen L, Pointon J, Wordsworth P.

Curr Opin Immunol. 2013 Feb;25(1):97-102. doi: 10.1016/j.coi.2012.11.002. Review.

PMID:
23452840
24.

Informed conditioning on clinical covariates increases power in case-control association studies.

Zaitlen N, Lindström S, Pasaniuc B, Cornelis M, Genovese G, Pollack S, Barton A, Bickeböller H, Bowden DW, Eyre S, Freedman BI, Friedman DJ, Field JK, Groop L, Haugen A, Heinrich J, Henderson BE, Hicks PJ, Hocking LJ, Kolonel LN, Landi MT, Langefeld CD, Le Marchand L, Meister M, Morgan AW, Raji OY, Risch A, Rosenberger A, Scherf D, Steer S, Walshaw M, Waters KM, Wilson AG, Wordsworth P, Zienolddiny S, Tchetgen ET, Haiman C, Hunter DJ, Plenge RM, Worthington J, Christiani DC, Schaumberg DA, Chasman DI, Altshuler D, Voight B, Kraft P, Patterson N, Price AL.

PLoS Genet. 2012;8(11):e1003032. doi: 10.1371/journal.pgen.1003032. Epub 2012 Nov 8.

25.

The impact of obstructive sleep apnea on aortic disease in Marfan's syndrome.

Kohler M, Pitcher A, Blair E, Risby P, Senn O, Forfar C, Wordsworth P, Stradling JR.

Respiration. 2013;86(1):39-44. doi: 10.1159/000340008. Epub 2012 Sep 20.

26.

A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.

Mackie SL, Taylor JC, Martin SG; YEAR Consortium; UKRAG Consortium, Wordsworth P, Steer S, Wilson AG, Worthington J, Emery P, Barrett JH, Morgan AW.

Genes Immun. 2012 Feb;13(2):120-8. doi: 10.1038/gene.2011.60. Epub 2011 Sep 1.

PMID:
21881596
27.

Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming.

Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, von Delft F, Kavanagh KL, Brown MA, Bowness P, Wordsworth P, Kessler BM, Oppermann U.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7745-50. doi: 10.1073/pnas.1101262108. Epub 2011 Apr 20.

28.

Analysis of association of DNASE2 promoter variation with rheumatoid arthritis in European Caucasians.

Phipps-Green A, McKinney C, Rossol M, Merriman ME, Topless R, Hollis-Moffatt JE, Wan Taib WR, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Wanger U, Wordsworth P, Merriman TR.

Ann Rheum Dis. 2011 Aug;70(8):1512-4. doi: 10.1136/ard.2010.138727. Epub 2011 Feb 12. No abstract available.

PMID:
21317435
29.

The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples.

Rodríguez-Rodríguez L, Taib WR, Topless R, Steer S, González-Escribano MF, Balsa A, Pascual-Salcedo D, González-Gay MA, Raya E, Fernandez-Gutierrez B, González-Álvaro I, Bottini N, Witte T, Viken MK, Coenen MJ, van Riel PL, Franke B, den Heijer M, Radstake TR, Wordsworth P, Lie BA, Merriman TR, Martín J.

Arthritis Rheum. 2011 Feb;63(2):365-72. doi: 10.1002/art.30145. Erratum in: Arthritis Rheum. 2011 Mar;63(3):669.

30.

The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009.

Evans DM, Reveille JD, Brown MA, Chandran V, Gladman DD, Martin TM, McGovern D, Wordsworth P, Inman RD.

J Rheumatol. 2010 Dec;37(12):2626-31. doi: 10.3899/jrheum.100892. Erratum in: J Rheumatol. 2011 Apr;38(4):788.

PMID:
21123336
31.

Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus.

Orozco G, Eyre S, Hinks A, Bowes J, Morgan AW, Wilson AG, Wordsworth P, Steer S, Hocking L; UKRAG consortium, Thomson W, Worthington J, Barton A.

Ann Rheum Dis. 2011 Mar;70(3):463-8. doi: 10.1136/ard.2010.137174. Epub 2010 Nov 10.

32.

Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease.

Eyre S, Hinks A, Bowes J, Flynn E, Martin P, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, Reid DM, Harrison P, Wordsworth P; Yorkshire Early Arthritis Consortium; Biologics in RA Control Consortium, Thomson W, Worthington J, Barton A.

Arthritis Res Ther. 2010;12(5):R175. doi: 10.1186/ar3139. Epub 2010 Sep 20.

33.

The revised Ghent nosology for the Marfan syndrome.

Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM.

J Med Genet. 2010 Jul;47(7):476-85. doi: 10.1136/jmg.2009.072785.

PMID:
20591885
34.

Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.

Eggleton P, Harries LW, Alberigo G, Wordsworth P, Viner N, Haigh R, Donnelly S, Jones HW, Chikanza IC, O'Conner TW, Thomson AE, Winyard PG.

J Clin Immunol. 2010 Sep;30(5):649-58. doi: 10.1007/s10875-010-9429-y. Epub 2010 Jun 9.

PMID:
20532967
35.

Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population.

Eyre S, Hinks A, Flynn E, Martin P, Wilson AG, Maxwell JR, Morgan AW, Emery P, Steer S, Hocking LJ, Reid DM, Harrison P, Wordsworth P, Thomson W, Worthington J, Barton A.

Ann Rheum Dis. 2010 Aug;69(8):1572-3. doi: 10.1136/ard.2009.122887. Epub 2009 Nov 27. No abstract available. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

36.

No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort.

Eyre S, Flynn E, Martin P, Hinks A, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, Reid DM, Harrison P, Wordsworth P, Thomson W, Worthington J, Barton A.

Ann Rheum Dis. 2010 Jul;69(7):1407-8. doi: 10.1136/ard.2009.120428. Epub 2009 Nov 11. No abstract available. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
19907058
37.

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.

Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, Catanese JJ, Xie G, Stahl EA, Chen R, Alfredsson L, Amos CI, Ardlie KG; BIRAC Consortium, Barton A, Bowes J, Burtt NP, Chang M, Coblyn J, Costenbader KH, Criswell LA, Crusius JB, Cui J, De Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TW, Kastner DL, Ke X, Kurreeman FA, Lee AT, Liu X, Li Y, Martin P, Morgan AW, Padyukov L, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AH, van der Horst-Bruinsma IE, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth P; YEAR Consortium, Altshuler D, Karlson EW, Toes RE, de Vries N, Begovich AB, Siminovitch KA, Worthington J, Klareskog L, Gregersen PK, Daly MJ, Plenge RM.

Nat Genet. 2009 Dec;41(12):1313-8. doi: 10.1038/ng.479. Epub 2009 Nov 8.

38.

Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci.

McClure A, Lunt M, Eyre S, Ke X, Thomson W, Hinks A, Bowes J, Gibbons L, Plant D, Wilson AG, Marinou I, Morgan AW, Emery P; BIRAC consortium, Steer S, Hocking LJ, Reid DM, Wordsworth P, Harrison P, Worthington J, Barton A.

Rheumatology (Oxford). 2009 Nov;48(11):1369-74. doi: 10.1093/rheumatology/kep272. Epub 2009 Sep 9. Erratum in: Rheumatology (Oxford). 2011 Jun;50(6):1178.

39.

Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.

Morgan AW, Thomson W, Martin SG; Yorkshire Early Arthritis Register Consortium, Carter AM; UK Rheumatoid Arthritis Genetics Consortium, Erlich HA, Barton A, Hocking L, Reid DM, Harrison P, Wordsworth P, Steer S, Worthington J, Emery P, Wilson AG, Barrett JH.

Arthritis Rheum. 2009 Sep;60(9):2565-76. doi: 10.1002/art.24752. Erratum in: Arthritis Rheum. 2010 Oct;62(10):3005. Arthritis Rheum. 2011 Mar;63(3):669.

40.

A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis.

Plant D, Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Gibbons LJ, Wilson AG, Marinou I, Morgan AW, Steer S, Hocking LJ, Reid DM, Wordsworth P, Harrison P, Worthington J.

Ann Rheum Dis. 2009 Aug;68(8):1373-5. doi: 10.1136/ard.2008.103572. No abstract available.

PMID:
19605748
41.

Challenges in mapping non-HLA-DRB1 major histocompatibility genes in rheumatoid arthritis: comment on the article by Vignal et al.

Brown M, Newton J, Harney SM, Wordsworth P.

Arthritis Rheum. 2009 Jul;60(7):2207; author reply 2207-8. doi: 10.1002/art.24624. No abstract available.

42.

PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.

Burr ML, Naseem H, Hinks A, Eyre S, Gibbons LJ, Bowes J, Wilson AG, Maxwell J, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Thomson W, Worthington J; BIRAC Consortium; YEAR Consortium, Barton A.

Ann Rheum Dis. 2010 Apr;69(4):666-70. doi: 10.1136/ard.2009.111294. Epub 2009 May 25. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

43.

Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study.

Orozco G, Eyre S, Hinks A, Ke X; Wellcome Trust Case Control consortium YEAR Consortium, Wilson AG, Bax DE, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Thomson W, Barton A, Worthington J.

Ann Rheum Dis. 2010 May;69(5):813-6. doi: 10.1136/ard.2009.109579. Epub 2009 May 11. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

44.

Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23.

Orozco G, Hinks A, Eyre S, Ke X, Gibbons LJ, Bowes J, Flynn E, Martin P; Wellcome Trust Case Control Consortium; YEAR consortium, Wilson AG, Bax DE, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Thomson W, Barton A, Worthington J.

Hum Mol Genet. 2009 Jul 15;18(14):2693-9. doi: 10.1093/hmg/ddp193. Epub 2009 May 5. Erratum in: Hum Mol Genet. 2010 Nov 15;19(22):4544.

45.

Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes.

Barton A, Eyre S, Ke X, Hinks A, Bowes J, Flynn E, Martin P; YEAR Consortium; BIRAC Consortium, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, Reid DM, Harrison P, Wordsworth P, Thomson W, Worthington J.

Hum Mol Genet. 2009 Jul 1;18(13):2518-22. doi: 10.1093/hmg/ddp177. Epub 2009 Apr 9. Erratum in: Hum Mol Genet. 2010 Nov 15;19(22):4543.

46.

Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.

Rudwaleit M, Claudepierre P, Wordsworth P, Cortina EL, Sieper J, Kron M, Carcereri-De-Prati R, Kupper H, Kary S.

J Rheumatol. 2009 Apr;36(4):801-8. doi: 10.3899/jrheum.081048. Epub 2009 Feb 27.

PMID:
19273449
47.

Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series.

Karaderi T, Harvey D, Farrar C, Appleton LH, Stone MA, Sturrock RD, Brown MA, Wordsworth P, Pointon JJ.

Rheumatology (Oxford). 2009 Apr;48(4):386-9. doi: 10.1093/rheumatology/ken501. Epub 2009 Feb 2. Erratum in: Rheumatology (Oxford). 2011 Jun;50(6):1179.

PMID:
19189980
48.

Refractory urticarial vasculitis responsive to anti-B-cell therapy.

Mukhtyar C, Misbah S, Wilkinson J, Wordsworth P.

Br J Dermatol. 2009 Feb;160(2):470-2. doi: 10.1111/j.1365-2133.2008.08990.x. Epub 2008 Dec 11. No abstract available.

PMID:
19120327
49.

The prevalence of obstructive sleep apnoea and its association with aortic dilatation in Marfan's syndrome.

Kohler M, Blair E, Risby P, Nickol AH, Wordsworth P, Forfar C, Stradling JR.

Thorax. 2009 Feb;64(2):162-6. doi: 10.1136/thx.2008.102756. Epub 2008 Oct 13.

50.

Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.

Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Plant D, Gibbons LJ; Wellcome Trust Case Control Consortium; YEAR Consortium; BIRAC Consortium, Wilson AG, Bax DE, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Worthington J.

Nat Genet. 2008 Oct;40(10):1156-9. doi: 10.1038/ng.218. Epub 2008 Sep 14.

Supplemental Content

Loading ...
Support Center